Oxytocin Buffers Stress Response in Individuals With Impaired Coping Abilities
Not Applicable
Completed
- Conditions
- Coping SkillsOxytocinStress
- Interventions
- Drug: Placebo
- Registration Number
- NCT01065610
- Lead Sponsor
- University of Osnabrueck
- Brief Summary
This study investigated, if people with impaired coping abilities benefit from intranasal oxytocin application.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
- male
Exclusion Criteria
- psychological disorders
- drug abuse
- cigarette smoking
- coronary diseases
- nervous system diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Placebo Placebo - Oxytocin Oxytocin Intranasal Oxytocin, 24 IU
- Primary Outcome Measures
Name Time Method Salivary Cortisol
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain oxytocin's stress-buffering effects in individuals with coping deficits?
How does intranasal oxytocin compare to standard stress management therapies in cortisol regulation?
Are there specific biomarkers that predict response to oxytocin in stress-related disorders?
What adverse events are associated with intranasal oxytocin administration in stress intervention studies?
What combination therapies enhance oxytocin's efficacy in managing stress responses for impaired coping populations?